Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Dowling

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 16, 2014
Stretched cell cycle model for proliferating lymphocytesMark R Dowling, Andrey Kan, Susanne Heinzel, et al.
Science (New York, N.Y.)|January 7, 2012
Activation-induced B cell fates are selected by intracellular stochastic competitionKen R Duffy, Cameron J Wellard, John F Markham, et al.
Transplantation and Cellular Therapy|May 11, 2026
Infections in the first 30-days after CAR-T therapy in Patients Not Receiving Fluoroquinolone ProphylaxisGemma K Reynolds, Mark R Dowling, Jose Valencia-Klug, et al.
Science (New York, N.Y.)|November 29, 2014
T cell signaling. Antigen affinity, costimulation, and cytokine inputs sum linearly to amplify T cell expansionJulia M Marchingo, Andrey Kan, Robyn M Sutherland, et al.
British Journal of Pharmacology|March 20, 2014
Investigating the molecular mechanisms through which FTY720-P causes persistent S1P1 receptor internalizationDavid A Sykes, Darren M Riddy, Craig Stamp, et al.
Blood Advances|April 3, 2020
Germline heterozygous mutations in Nxf1 perturb RNA metabolism and trigger thrombocytopenia and lymphopenia in miceStéphane Chappaz, Charity W Law, Mark R Dowling, et al.
Transplantation and Cellular Therapy|May 30, 2026
A critical review of clinical factors and tools for predicting chimeric antigen receptor T-cell toxicitiesJian Li, Mark R Dowling, Miriam Wronski, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 26, 2006
In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of actionCliff Battram, Steven J Charlton, Bernard Cuenoud, et al.
Science Immunology|October 28, 2022
Long-lived plasma cells accumulate in the bone marrow at a constant rate from early in an immune responseMarcus James Robinson, Mark R Dowling, Catherine Pitt, et al.
Immunity|May 10, 2023
Intrinsically determined turnover underlies broad heterogeneity in plasma-cell lifespanMarcus James Robinson, Zhoujie Ding, Mark R Dowling, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|April 16, 2014
Stretched cell cycle model for proliferating lymphocytesMark R Dowling, Andrey Kan, Susanne Heinzel, et al.
Science (New York, N.Y.)|January 7, 2012
Activation-induced B cell fates are selected by intracellular stochastic competitionKen R Duffy, Cameron J Wellard, John F Markham, et al.
Transplantation and Cellular Therapy|May 11, 2026
Infections in the first 30-days after CAR-T therapy in Patients Not Receiving Fluoroquinolone ProphylaxisGemma K Reynolds, Mark R Dowling, Jose Valencia-Klug, et al.
Science (New York, N.Y.)|November 29, 2014
T cell signaling. Antigen affinity, costimulation, and cytokine inputs sum linearly to amplify T cell expansionJulia M Marchingo, Andrey Kan, Robyn M Sutherland, et al.
British Journal of Pharmacology|March 20, 2014
Investigating the molecular mechanisms through which FTY720-P causes persistent S1P1 receptor internalizationDavid A Sykes, Darren M Riddy, Craig Stamp, et al.
Blood Advances|April 3, 2020
Germline heterozygous mutations in Nxf1 perturb RNA metabolism and trigger thrombocytopenia and lymphopenia in miceStéphane Chappaz, Charity W Law, Mark R Dowling, et al.
Transplantation and Cellular Therapy|May 30, 2026
A critical review of clinical factors and tools for predicting chimeric antigen receptor T-cell toxicitiesJian Li, Mark R Dowling, Miriam Wronski, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 26, 2006
In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of actionCliff Battram, Steven J Charlton, Bernard Cuenoud, et al.
Science Immunology|October 28, 2022
Long-lived plasma cells accumulate in the bone marrow at a constant rate from early in an immune responseMarcus James Robinson, Mark R Dowling, Catherine Pitt, et al.
Immunity|May 10, 2023
Intrinsically determined turnover underlies broad heterogeneity in plasma-cell lifespanMarcus James Robinson, Zhoujie Ding, Mark R Dowling, et al.
Pageof 6